Guillain Barré Syndrome in children and adolescents during epidemic outbreaks
DOI:
https://doi.org/10.61997/bjm.v14i2.456Keywords:
Epidemics, Guillain-Barre Syndrome, PediatricsAbstract
Background: Guillain-Barré syndrome is a rapidly progressive and immune-mediated polyneuropathy, rare in pediatrics, and is the most common cause of acute flaccid paralysis in childhood; the incidence is estimated at 0.34 to 1.34 per 100,000 people per year; Generally, it is associated with a history of infectious processes prior to the onset of motor symptoms in up to 50%-82% of cases. Objective: To generate an updated review on Guillain Barré Syndrome in children and adolescents and its relationship with the increase in cases in outbreaks of infectious diseases. Methods: A search of references published in the pubmed.gov database was carried out, period 2019-2024 in English, a total of 388 publications were obtained, selecting a total of n=47 that were included in this review and n=3 national reference publications. Those publications such as in response to, letters to the editor or editorial were excluded. Conclusion: Guillain Barré Syndrome is a rare condition in children and adolescents; however, it is the main cause of flaccid paralysis in childhood, with evidence in the literature about the increase in cases during epidemics, particularly those of a viral type such as arboviruses and recently SARS CoV-2.
Downloads
References
Levison LS, Thomsen RW, Markvardsen LK, Christensen DH, Sindrup SH, Andersen H. Pediatric Guillain-Barre Syndrome in a 30-Year Nationwide Cohort. Pediatr Neurol. 2020;107:57-63. doi: 10.1016/j.pediatrneurol.2020.01.017 DOI: https://doi.org/10.1016/j.pediatrneurol.2020.01.017
Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barre syndrome. Lancet. 2021; 397(10280):1214-28. doi: 10.1016/S0140-6736(21)00517-1 DOI: https://doi.org/10.1016/S0140-6736(21)00517-1
Pimentel V, Luchsinger VW, Carvalho GL, Alcara AM, Esper NB, Marinowic D, et al. Guillain-Barre syndrome associated with COVID-19: A systematic review. Brain Behav Immun Health. 2023; 28:100578. doi: 10.1016/j.bbih.2022.100578 DOI: https://doi.org/10.1016/j.bbih.2022.100578
Korinthenberg R, Trollmann R, Felderhoff-Muser U, Bernert G, Hackenberg A, Hufnagel M, et al. Diagnosis and treatment of Guillain-Barre Syndrome in childhood and adolescence: An evidence- and consensus-based guideline. Eur J Paediatr Neurol. 2020; 25:5-16. doi: 10.1016/j.ejpn.2020.01.003 DOI: https://doi.org/10.1016/j.ejpn.2020.01.003
Prashanth A, Shende V, Pawar S. A Study of Sensory Nerve Conduction in Pre- and Post-immunoglobulin Treatment of Guillain-Barre Syndrome. Cureus. 2024; 16(1):e51673. doi: 10.7759/cureus.51673 DOI: https://doi.org/10.7759/cureus.51673
Organización Mundial de la Salud. Síndrome de Guillain-Barré. Ginebra, Suiza: OMS, 2023. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/guillain-barré-syndrome
Al Jaberi M, Shihadat R, Masri A. Post SARS-CoV-2 Guillain-Barre syndrome in a child: case report and review of the literature. Childs Nerv Syst. 2022; 38(10):2011-6. doi: 10.1007/s00381-022-05536-1 DOI: https://doi.org/10.1007/s00381-022-05536-1
Wachira VK, Farinasso CM, Silva RB, Peixoto HM, de Oliveira MRF. Incidence of Guillain-Barre syndrome in the world between 1985 and 2020: A systematic review. Glob Epidemiol. 2023; 5:100098. doi: 10.1016/j.gloepi.2023.100098 DOI: https://doi.org/10.1016/j.gloepi.2023.100098
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain-Barre syndrome in ten steps. Nat Rev Neurol. 2019; 15(11):671-83. doi: 10.1038/s41582-019-0250-9 DOI: https://doi.org/10.1038/s41582-019-0250-9
Abu-Rumeileh S, Abdelhak A, Foschi M, Tumani H, Otto M. Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases. J Neurol. 2021; 268(4):1133-70. doi: 10.1007/s00415-020-10124-x DOI: https://doi.org/10.1007/s00415-020-10124-x
Langille MM. Guillain-Barre Syndrome in Children and Adolescents. Adv Pediatr. 2023; 70(1):91-103. doi: 10.1016/j.yapd.2023.04.001 DOI: https://doi.org/10.1016/j.yapd.2023.04.001
Li Y, Zhao R, Li L, Xue H, Meng H, Li G, et al. Relative frequencies and clinical features of Guillain-Barré Syndrome before and during the COVID-19 pandemic in North China. BMC Infectious Diseases. 2024; 24(1):541-8. doi: 10.1186/s12879-024-09401-1 DOI: https://doi.org/10.1186/s12879-024-09401-1
Omura S, Shimizu K, Kuwahara M, Morikawa-Urase M, Kusunoki S, Tsunoda I. Exploratory factor analysis determines latent factors in Guillain-Barre syndrome. Sci Rep. 2022; 12(1):21837. doi: 10.1038/s41598-022-26422-5 DOI: https://doi.org/10.1038/s41598-022-26422-5
Cavirani B, Baga M, Cesaroni CA, Rizzi S, Spagnoli C, Frattini D, et al. Guillain-Barre Syndrome-Retrospective Analysis of Data from a Cohort of Patients Referred to a Tertiary Care Pediatric Neuromuscular Center from 2000 to 2017: Electrophysiological Findings, Outcomes, and a Brief Literature Review. Medicina (Kaunas). 2024; 60(9). doi: 10.3390/medicina60091490 DOI: https://doi.org/10.3390/medicina60091490
Rangan RS, Tullu MS, Deshmukh CT, Mondkar SA, Agrawal M. Clinical Profile and Outcome of Guillain-Barre Syndrome in Pediatric Patients Admitted to a Tertiary Care Centre: A Retrospective Study. Neurol India. 2021; 69(1):81-4. doi: 10.4103/0028-3886.310112 DOI: https://doi.org/10.4103/0028-3886.310112
Helfferich J, Roodbol J, de Wit MC, Brouwer OF, Jacobs BC, Enterovirus DAFMWG, et al. Acute flaccid myelitis and Guillain-Barre syndrome in children: A comparative study with evaluation of diagnostic criteria. Eur J Neurol. 2022; 29(2):593-604. doi: 10.1111/ene.15170 DOI: https://doi.org/10.1111/ene.15170
Florian IA, Lupan I, Sur L, Samasca G, Timis TL. To be, or not to be... Guillain-Barre Syndrome. Autoimmun Rev. 2021; 20(12):102983. doi: 10.1016/j.autrev.2021.102983 DOI: https://doi.org/10.1016/j.autrev.2021.102983
Ashrafi MR, Mohammadalipoor A, Naeini AR, Amanat M, Tavasoli AR, Heidari M, et al. Clinical Characteristics and Electrodiagnostic Features of Guillain-Barre Syndrome Among the Pediatric Population. J Child Neurol. 2020; 35(7):448-55. doi: 10.1177/0883073820905157 DOI: https://doi.org/10.1177/0883073820905157
Wahatule R, Dutta D, Debnath M, Nagappa M, Mahadevan A, Sinha S, et al. Ganglioside complex antibodies in an Indian cohort of Guillain-Barre syndrome. Muscle Nerve. 2020; 62(6):728-34. doi: 10.1002/mus.27071 DOI: https://doi.org/10.1002/mus.27071
Javankiani S, Nasrollahizadeh A, Gharib B, Heidari M, Memarian S. The characteristics of Guillain-Barre syndrome in children in pre-COVID-19 and during the COVID-19 pandemic: A cross-sectional study. Health Sci Rep. 2023; 6(12):e1782. doi: 10.1002/hsr2.1782 DOI: https://doi.org/10.1002/hsr2.1782
Luo HY, Li XJ, Cheng M, Wang J, Xie LL, Yao ZX, et al. Clinical characteristics of children with Guillain-Barre syndrome and factors associated with disease severity. J Clin Neurosci. 2021; 92:120-5. doi: 10.1016/j.jocn.2021.08.001 DOI: https://doi.org/10.1016/j.jocn.2021.08.001
Galeas Oliva M, Ramos F. Síndrome de Guillain Barré Recurrente: Reporte de caso. Acta Pediátrica Hondureña. 2017; 8(2):791-5. Disponible en: http://www.bvs.hn/APH/pdf/APHVol8/pdf/APHVol8-2-2017-2018-6 DOI: https://doi.org/10.5377/pediatrica.v8i2.7980
Sreelakshmi V, Pattanaik A, Marate S, Mani RS, Pai AR, Mukhopadhyay C. Guillain-barre syndrome (GBS) with antecedent chikungunya infection: a case report and literature review. Neurol Res Pract. 2024; 6(1):21. doi: 10.1186/s42466-024-00315-6 DOI: https://doi.org/10.1186/s42466-024-00315-6
Sharma P, Surve RM, Pendharkar HS, Kulkarni GB, Naik SS. Mimics of Guillain-Barre Syndrome in Pediatric Patients Admitted to the Neuro-Intensive Care Unit of a Tertiary Care Hospital-A Case Series. Neurol India. 2024; 72(2):379-83. doi: 10.4103/ni.ni_881_22 DOI: https://doi.org/10.4103/ni.ni_881_22
Dutta D, Debnath M, Seshagiri DV, Nair BVS, Das SK, Wahatule R, et al. Impact of Antecedent Infections on the Antibodies against Gangliosides and Ganglioside Complexes in Guillain-Barre Syndrome: A Correlative Study. Ann Indian Acad Neurol. 2022; 25(3):401-6. doi: 10.4103/aian.aian_121_22 DOI: https://doi.org/10.4103/aian.aian_121_22
Censi S, Bisaccia G, Gallina S, Tomassini V, Uncini A. Guillain-Barre syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the 'Italian factor'. Eur J Neurol. 2024; 31(2):e16094. doi: 10.1111/ene.16094 DOI: https://doi.org/10.1111/ene.16094
Li X, Yang L, Wang G, Yuan Y, Wei N, Yang W, et al. Extensive cytokine biomarker analysis in serum of Guillain-Barre syndrome patients. Sci Rep. 2023; 13(1):8354. doi: 10.1038/s41598-023-35610-w DOI: https://doi.org/10.1038/s41598-023-35610-w
Frank CHM, Almeida TVR, Marques EA, de Sousa Monteiro Q, Feitoza PVS, Borba MGS, et al. Guillain-Barre Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient. J Trop Pediatr. 2021; 67(3). doi: 10.1093/tropej/fmaa044 DOI: https://doi.org/10.1093/tropej/fmaa044
Manji HK, George U, Mkopi NP, Manji KP. Guillain-Barre syndrome associated with COVID-19 infection. Pan Afr Med J. 2020; 35(Suppl 2):118. doi: 10.11604/pamj.supp.2020.35.2.25003
Malamud E, Caress JB, Lapid DJ, Otallah SI. "Guillain-Barre Syndrome After COVID-19 Vaccination in an Adolescent" [Pediatric Neurology, Volume 126, January 2022, Pages 9-10]. Pediatr Neurol. 2022; 128:77. doi: 10.1016/j.pediatrneurol.2021.11.001 DOI: https://doi.org/10.1016/j.pediatrneurol.2021.11.001
Curtis M, Bhumbra S, Felker MV, Jordan BL, Kim J, Weber M, et al. Guillain-Barre Syndrome in a Child With COVID-19 Infection. Pediatrics. 2021; 147(4). doi: 10.1542/peds.2020-015115 DOI: https://doi.org/10.1542/peds.2020-015115
Akcay N, Menentoglu ME, Bektas G, Sevketoglu E. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child. J Med Virol. 2021; 93(9):5599-602. doi: 10.1002/jmv.27018 DOI: https://doi.org/10.1002/jmv.27018
Olbert E, Alhani N, Struhal W. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series. Wien Med Wochenschr. 2024; 174(1-2):30-4. doi: 10.1007/s10354-023-01018-4 DOI: https://doi.org/10.1007/s10354-023-01018-4
Martinelli-Boneschi F, Colombo A, Bresolin N, Sessa M, Bassi P, Grampa G, et al. COVID-19-associated Guillain-Barre syndrome in the early pandemic experience in Lombardia (Italy). Neurol Sci. 2023; 44(2):437-46. doi: 10.1007/s10072-022-06429-6 DOI: https://doi.org/10.1007/s10072-022-06429-6
Hagen KM, Ousman SS. The Neuroimmunology of Guillain-Barre Syndrome and the Potential Role of an Aging Immune System. Front Aging Neurosci. 2020; 12:613628. doi: 10.3389/fnagi.2020.613628 DOI: https://doi.org/10.3389/fnagi.2020.613628
van Doorn PA, Van den Bergh PYK, Hadden RDM, Avau B, Vankrunkelsven P, Attarian S, et al. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barre syndrome. Eur J Neurol. 2023; 30(12):3646-74. doi: 10.1111/ene.16073 DOI: https://doi.org/10.1111/ene.16073
Scallan Walter EJ, Crim SM, Bruce BB, Griffin PM. Incidence of Campylobacter-Associated Guillain-Barre Syndrome Estimated from Health Insurance Data. Foodborne Pathog Dis. 2020; 17(1):23-8. doi: 10.1089/fpd.2019.2652 DOI: https://doi.org/10.1089/fpd.2019.2652
Dutta D, Debnath M, Nagappa M, Das SK, Wahatule R, Sinha S, et al. Antecedent infections in Guillain-Barre syndrome patients from south India. J Peripher Nerv Syst. 2021; 26(3):298-306. doi: 10.1111/jns.12459 DOI: https://doi.org/10.1111/jns.12459
Estublier B, Colineaux H, Arnaud C, Cintas P, Baudou E, Chaix Y, et al. Long-term outcomes of paediatric Guillain-Barre syndrome. Dev Med Child Neurol. 2024; 66(2):176-86. doi: 10.1111/dmcn.15693 DOI: https://doi.org/10.1111/dmcn.15693
Sen S, Kumar A, Roy B. Clinical Outcome of Guillain-Barre Syndrome in 108 Children. Indian Pediatr. 2021; 58(9):833-5. doi: 10.1007/s13312-021-2302-7 DOI: https://doi.org/10.1007/s13312-021-2302-7
Garnero M, Del Sette M, Assini A, Beronio A, Capello E, Cabona C, et al. COVID-19-related and not related Guillain-Barre syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy. J Neurol Sci. 2020; 418:117114. doi: 10.1016/j.jns.2020.117114 DOI: https://doi.org/10.1016/j.jns.2020.117114
Aladawi M, Elfil M, Abu-Esheh B, Abu Jazar D, Armouti A, Bayoumi A, et al. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review. Can J Neurol Sci. 2022; 49(1):38-48. doi: 10.1017/cjn.2021.102 DOI: https://doi.org/10.1017/cjn.2021.102
Christie CDC, Lue AM, Melbourne-Chambers RH. Dengue, chikungunya and zika arbovirus infections in Caribbean children. Curr Opin Pediatr. 2023; 35(2):155-65. doi: 10.1097/MOP.0000000000001229 DOI: https://doi.org/10.1097/MOP.0000000000001229
Leung J, Sejvar JJ, Soares J, Lanzieri TM. Guillain-Barre syndrome and antecedent cytomegalovirus infection, USA 2009-2015. Neurol Sci. 2020; 41(4):885-91. doi: 10.1007/s10072-019-04156-z DOI: https://doi.org/10.1007/s10072-019-04156-z
del Carpio Orantes L, Cerda Méndez C, Jiménez García R, Garma García A, López Cabrera Y, Flores Salguero L, et al. Síndrome de Guillain Barré asociado a los brotes de Zika, deBrasil a México. Neurología Argentina. 2020; 12(3):147-52. doi: 10.1016/j.neuarg.2020.06.002 DOI: https://doi.org/10.1016/j.neuarg.2020.06.002
Ramírez Izcoa A, Izaguirre González A, Cerna Lizardo J, Hernandez Bustillo G, Cordova Tello D. Síndrome de Guillain Barré en paciente pediátrico: Diagnóstico y Rehabilitación. Reporte de caso. Rev Med Hondur. 2016; 84(3 y 4):118-22. Disponible en: https://camjol.info/index.php/RMH/article/view/12380
Zavala C, Aguilera G. Síndrome de Guillain Barre Crónico o Recurrente. Rev Med Hondur. 1996;64(4):149-52. Disponible en: https://pesquisa.bvsalud.org/portal/resource/pt/lil-200255
Sudeep KC, Bansal A, Randhawa MS, Muralidharan J, Nallasamy K, Angurana SK, et al. Recurrent Guillain-Barre Syndrome: Clinical Profile and Outcome. Indian J Pediatr. 2024; 91(5):448-54. doi: 10.1007/s12098-023-04746-y DOI: https://doi.org/10.1007/s12098-023-04746-y
Rajurkar RD, Patil DS, Jagzape MV. Pediatric Physiotherapeutic Approach for Guillain-Barre Syndrome Associated With Dengue Fever: A Case Report. Cureus. 2023; 15(10):e46488. doi: 10.7759/cureus.46488 DOI: https://doi.org/10.7759/cureus.46488
Chafiq K, Hadzine Y, Elmekkaoui A, Benlenda O, Rajad H, Wakrim S, et al. Navigating the complexity of Guillain-Barre syndrome and Miller-Fisher syndrome overlap syndrome: a pediatric case report. Pan Afr Med J. 2024; 47:127. doi: 10.11604/pamj.2024.47.127.42985 DOI: https://doi.org/10.11604/pamj.2024.47.127.42985
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Andrea Estefanía Ramos Ortega, Scheybi Teresa Miralda Méndez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
BJM protects Copyright at all times. However, it gives up part of the rights by displaying a Creative Commons License 4.0 (cc-by-nc), which allows the use of the work to share (copy and redistribute the material in any support or format) and adapt (transform and built from the material) as long as exclusive mention of the publication in the journal as the primary source is made. Under no circumstances, the work can be commercialized.
